目的 探讨分析品管圈在提高腔镜肾癌术后护理流程管理中的应用,以提高肾癌术后患者的存活率也避免术后并发症出现。方法 对我院肾癌术后护理流程管理的现状进行分析,并将目前我院在肾癌术后护理流程管理当中出现的问题进行分析探讨和总结,并制定出详细的工作目标拟定可行的工作计划,并组织人员进行实施,并将实施之后的结果与预期的结果进行对比分析总结。结果 在实施了品管圈活动之后,我院对腔镜肾癌术后护理流程的管理得到了显著的提升,其中人员操作不规范的发生率由实施活动之前的13.2%(5/38)减低到了5.3%(2/38),同时患者发生术后并发症的例数也由之前的7例降低到了3例,结果对比较之前的差异有统计学意义。结论 使用品管圈活动不仅能够有效的提高对腔镜肾癌术后护理流程管理中的效力,而且还能够减少患者术后并发症的发生几率。

目的 追踪随访186例甲状腺微小乳头状癌(Papillary Thyroid Microcarcinoma,PMC)患者术后5年及10年的肿瘤复发率、生存率、及术后并发症,探讨不同手术方式对治疗甲状腺微小乳头状癌预后。方法 临床资料为1993—2003年收治的186例甲状腺微小乳头状癌患者,102例行患侧甲状腺大部分切除术(Ⅰ组),84例行患侧甲状腺全切术+峡部切除+对侧甲状腺大部分切除+中央区淋巴结清扫术(Ⅱ组)。结果 Ⅰ组患者术后5年及10年期间肿瘤复发率、生存率与Ⅱ组差别无统计学意义(P﹥0.05),对比I组,Ⅱ组患者术后发生甲状腺及甲状旁腺功能低下的发生率较高,且差别有统计学意义(P﹤0.05)。结论 甲状腺微小乳头状癌预后良好,实行患侧甲状腺大部分切除术对治疗甲状腺微小乳头状癌是安全可行的。

Objective To follow-up 186 cases of papillary thyroid microcarcinoma and analyse their tumor recurrence rate、survival rate and complicationg after 5 and 10 years postoperation, to investigate prognosis of papillary thyroid microcarcinoma from different operation approaches. Methods 186 cases of papillary thyroid microcarcinoma were from 1993 to 2003. All the patients were divided into two groups,102 cases(group Ⅰ) performed with resection of the majority of thyroid gland, and 84 caces(group Ⅱ) performed with total thyroidectomy, thyroidectomy+isthmus thyroidectomy+contralateral thyroid lobectomy+central lymph node ablation. Results The recurrence and survival rates after 5 and 10 years were not significantly different between the two groups, but compared group Ⅰ, the incidences of hypocalcemia and hypothyroidism were higher in group Ⅱ(P<0.05). Conclusion Papillary thyroid microcarcinoma had better prognosis. Resection of the majority of thyroid gland treating papillary thyroid microcarcinoma is safe and feasible.

目的 探讨注射用黄芪多糖对宫颈癌化疗患者骨髓抑制的影响。方法 选取2012年11月—2015年10月于我院接受治疗的宫颈癌患者110例,随机分为对照组和观察组,每组各55例,两组患者均接受紫杉醇联合顺铂同步放疗,而观察组患者在此基础上接受每日静脉滴注注射用黄芪多糖治疗,连续应用10天。对比分析两组患者的临床疗效以及治疗前后的血象。结果 经过治疗后,观察组的治疗总有效率为61.81%,明显高于对照组的38.18%,差异有统计学意义(P<0.05);两组患者经过放化疗后其白细胞、红细胞和血小板计数均有不同程度的降低,而与对照组相比,观察组患者下降不明显。结论 注射用黄芪多糖可以减轻宫颈癌放化疗所致的骨髓抑制,对骨髓具有一定的保护作用,在临床治疗宫颈癌的过程中值得推广应用。

Objective To explore the clinical effect of astragalus polysaccharides on protecting marrow suppression of cervical carcinoma after chemotherapy. Methods 110 cases of patients with cervical carcinoma treated in our hospital from November 2012 to October 2015 in our hospital were selected and divided into control group and observation group, each group contains 55 cases. Both groups of patients received radiotherapy and chemotherapy of paclitaxel combined with cisplatin, and the observation group additionally received intravenous injection of astragalus polysaccharides for 10 days, to compare the hemogram before and after treatments between two groups. Results After treatments, the total effective rate of the observation group was 61.81%, significantly higher than that of the control group, the difference was statistically significant (P<0.05); The white blood cell, red blood cell and platelet count reduced in two goups after treatment. Compared with the control group, there was no significant decrease in the observation group. Conclusion Astragalus polysaccharides injection may reduce the marrow suppression induced by radiotherapy and chemotherapy in the treatment of cervical cancer, and it has a protective effect on the bone marrow.

目的 探究在合并桥本甲状腺炎的甲状腺乳头状癌治疗过程中,应用不同手术方式对其进行治疗后的效果。方法 选取2015年04月—2016年05月在我院进行手术治疗的87例单侧甲状腺乳头状癌合并桥本甲状腺炎患者,并将所有患者按照不同的手术方式分为两组,分别命为观察组、对照组。观察组44例患者选择患侧甲状腺腺叶+峡部切除的术式,对照组43例患者选择全甲状腺切除的术式。对比两组应用不同术式治疗后的甲状旁腺功能及甲状腺功能的变化,术中出血量、切口长度及手术时间。结果 观察组的甲状旁腺功能低下率(0.00%)、甲状腺功能低下率(2.27%)以及切口长度 (4.00±1.10)cm、术中出血量(33.60±8.30)mL、手术时间(130.73±34.67)min均低于对照组的甲状旁腺功能低下率(11.63%)、甲状腺功能低下率(97.67%)以及切口长度 (9.70±2.33)cm、术中出血量(76.70±23.90)mL、手术时间(160.94±39.70)min,差异有统计学意义(P＜0.05)。结论 合并桥本甲状腺炎的甲状腺乳头状癌患者采用患侧甲状腺腺叶+峡部切除术的治疗效果显著,可有效降低甲状旁腺及甲状腺功能低下几率的发生,改善术中出血量、切口长度及手术时间相关指标。

Objective To explore clinical efficacy of different surgical methods in treatment of papillary thyroid cancinoma combined Hashimoto's thyroiditis. Methods Eighty-seven patients of unilateral papillary thyroid carcinoma in patients with Hashimoto's thyroiditis who were treated in our hospital between April 2015 and May 2016 were divided into two groups according to surgical treatment methods, namely observation group and control group. Forty-four patients in the observation group received ipsilateral thyroid lobe + isthmus resection, while forty-three patients in the control group were given total thyroidectomy. Changes of parathyroid and thyroid functions, intraoperative blood loss, length of incision and operation time after different surgical procedures were compared. Results The hypoparathyroidism rate (0.00%), hypothyroidism rate (2.27%), and incision length (4.00±1.10)cm, blood loss (33.60±8.30)mL, operation time (130.73±34.67)min in the observation group were lower than those in the control group (11.63%), (97.67%), (9.70±2.33)cm, (76.70±23.90)mL, (160.94±39.70) min, the difference was statistically significant (P<0.05). Conclusion Ipsilateral thyroid lobe and isthmus resection shows obvious effect in treatment of papillary thyroid carcinoma with Hashimoto's thyroiditis, effectively reduces the incidence of parathyroid and thyroid dysfunction, improves intraoperative blood loss, length of incision and operation time.

目的 观察鼻咽癌患者癌组织中RhoA蛋白-Rho激酶蛋白表达情况。方法 收集增城市人民医院2009年2月—2014年6月耳鼻喉科住院治疗,进行活检的鼻咽癌患者切除标本共62例,包括癌组织及癌旁组织。通过SABC免疫组织化学法检测患者癌组织及癌旁组织中RhoA蛋白-Rho激酶蛋白表达情况。结果 鼻咽癌组织RhoA蛋白阳性表达率及Rho激酶蛋白阳性率高于癌旁组织(P=0.00);鼻咽癌癌组织RhoA及Rho激酶表达在年龄及性别分布上无差异,而TNM分期中Ⅲ期+Ⅳ期RhoA及Rho激酶表达阳性率高于Ⅰ期+Ⅱ期患者,同时存在淋巴结转移患者其RhoA及Rho激酶表达阳性率高于未转移患者。结论 鼻咽癌患者癌组织中RhoA蛋白及Rho激酶表达阳性率高,TNM分期越高及存在淋巴结转移者其RhoA蛋白及Rho激酶表达阳性率越高。RhoA-Rho激酶信号通路参与了鼻咽癌发生发展的过程。

Objective To observe the expression of RhoA-Rho kinase protein in patients with nasopharyngeal carcinoma tissue. Methods Collecting 62 cases of patients with nasopharyngeal carcinoma who hospitalized and hadbiopsyof specimens, including carcinoma tissues and adjacent tissues in department of otolaryngology-head and neck surgery from February 2010 to October 2014. The expression of RhoA-Rho kinase protein in carcinoma tissues and adjacent tissues was detected with SABC immune histochemical method. Results Positive expression rate of nasophryngeal carcinoma tissue RhoA protein and Rho kinase protein was significantly higher than that of adjacent tissues, and there was no obvious difference in age and sex between the expression of nasopharyngeal carcinoma tissue RhoA and Rho kinase(P=0.00), while patients being in the third and fourth periods of TNM stage had a higher positive expression rate of RhoA and Rho kinase than those being in the first and second periods. At the same time, RhoA and Rho kinase positive expression rate in patients with lymph node metastasis was higher than that in those without lymph node metastasis. Conclusion Positive expression rate of RhoA protein and Rho kinase in patients with nasopharyngeal carcinoma. The higher TNM stage is, the higher positive expression rate of RhoA protein and Rho kinase in lymph node metastasis is. RhoA-Rho kinase signaling pathways involved in the occurrence and development of nasopharyngeal carcinoma.

目的 观察改良INP方案对肺腺癌伴有脑转移患者的临床疗效及毒副作用,并探讨该方案疗效与Ⅲ型β微管蛋白(β-tubulin-Ⅲ)在肺癌组织中表达水平的关系。方法 收集2010年4月—2013年1月广州医科大学附属第一医院胸外科收治的15例肺腺癌伴有脑转移患者的临床资料。所有患者均采用改良INP方案治疗,使用RECIST 1.0标准进行判定。结果 脑转移瘤取得CR 1例(1/15),PR 5例(5/15),SD 4例(4/15),PD 5例 (5/10),该方案对脑转移瘤的总缓解率(overall response rate,ORR)为40%,疾病控制率(disease control rate,DCR)达66.7%,毒副作用轻度可控;Ⅲ型β微管蛋白低表达对该方案的疗效有优于高表达的趋势。结论 肺腺癌伴有脑转移患者采用改良INP方案进行化疗,脑转移瘤临床疾病控制率较高,耐受性良好;肿瘤组织β-tubulin-Ⅲ表达水平可能与该方案的疗效相关。

Objective To investigate the efficacy and toxicity of chemotherapy of modified INP regimen in the treatment of adenocarcinoma with brain metastases. At the same time,to explore the relationship between expression of β-tubulin-Ⅲ in NSCLC biopsies and sensitivity to this modified INP regimen. Methods The clinical data of 15 adenocarcinoma with brain metastases patients who had been admitted to the first affiliated hospital of Guangzhou medical university from April 2010 to January 2013 were retrospectively analyzed. All patients received modified INP regimen.RECIST 1.0 was taken to know the result. Results For brain metastasis of the 15 patients, complete response (CR) and partial response(PR) were 1 and 5 patients, respectively. 4 patients were stable disease (SD) and progression disease(PD) in 5 patients. The overall response rate(ORR) was 40% and the disease control rate(DCR) was 66.7%. The toxicity was mild. Furthermore, we found NSCLC patients with low β-tubulin-Ⅲexpression had better ORR than those with high expression. Conclusion The modified INP regimen is effective and well-tolerable for brain metastases of adenocarcinoma. The β-tubulin-Ⅲ expression may be associated with the efficacy of this regimen.

目的 回顾性分析支气管肺泡细胞癌(bronchioloalveolar carcinoma,BAC)临床特点,提高早期BAC的确诊率,减少误诊。方法 对2013年—2014年间在我院确诊的BAC病例5例的临床资料进行回顾性分析。结果 5例患者中男4例,女1例,年龄在50～73岁之间,在社区医院均曾误诊为肺炎,所有患者均在我院经支气管镜肺活检后确诊为BAC。结论 BAC是一种较为特殊的肺癌,临床上症状无特异性,极易误诊为普通肺炎。由于BAC预后差,误诊后果严重,对初诊为普通肺炎的患者经常规抗感染治疗后临床症状及影像学表现改善不明显时,应及时进行各项检查、明确诊断,以便有效改善患者预后。

Objective To elevate the clinical diagnosis of BAC (bronchioloalveolar carcinoma) so as to reduce misdiagnosis by using retrospective analyses. Methods Retrospective analyses were used to study the five BAC patients, who were diagnosed in our hospital from 2013 to 2014. Results 4 of 5 male, and 1 female, age between 50 and 73, were diagnosed as pneumonia. All of them were made a definite diagnosis as BAC after performing transbronchial lung biopsy. Conclusion BAC is an exceptional lung adenocarcinoma and there is no specific clinic symptom. BAC was easily misdiagnosed as common lung pneumonia. There will be serious consequences after misdiagnosis of BAC due to its poor prognosis. Those patients who were misdiagnosed as common lung disease, but there was no obvious improvement after accepting long anti-infective therapy and there was negatively detection of pathogenic bacteria in them, are needed to perform all other clinical examination to clarify a diagnosis, and to further improve the prognosis of the patients.

目的 分析总结12例原发性肺淋巴上皮瘤样癌(LELC)的临床病理特点。方法 回顾性分析12例肺LELC患者的临床病理资料。结果 12例肺LELC患者的组织学标本中,肿瘤细胞均明显表达HCK,原位杂交EBER阳性率为91.7%。全组中位生存期61.3个月,2年和5年生存率分别为84.6%和57.7%。结论 原发性肺LELC临床罕见,发病可能与EB病毒感染有关,经及时治疗有较好的预后。

Objective To investigate the pathological and clinical significance of 12 cases with primary Lymphoepithelioma-like carcinoma of the lung (LELC). Methods Retrospectively detectded and analyzed the clincalpathological feature of 12 cases of LELC of the lung. Results Histological study showed that tumor cells were significantly expressed HCK by immunohistochemistry staining and showed out 91.7% positive rate of EBER by situ hybridization. In this series, the median survival time was 61.3 months. The overall 2 and 5 year survival rates of the 12 cases were 84.6% and 57.7%. Conclusion Pulmonary LELC is very rare. It may be associated with Epstein-Barr virus infection, and has a batter prognosis after therapy.